Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. Dezember 2023 07:00 ET | Quelle: AlloVir Inc.

AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy

Company to discontinue its three Phase 3 posoleucel studies following separate, pre-planned DSMB futility analyses concluding the studies were unlikely to meet their primary endpoints; no safety...
26. Mai 2021 09:10 ET | Quelle: Research Dive

Growing Focus of Pharma Companies on Developing Drugs for COVID-19 Treatment to Foster the Growth of Antiviral Therapy Market during Pandemic - Exclusive Report [Pages-150] by Research Dive

New York, USA, May 26, 2021 (GLOBE NEWSWIRE) -- The global antiviral therapy market is likely to witness an increase in the growth rate due to the COVID-19 pandemic. According to a latest report...
14. Dezember 2020 09:00 ET | Quelle: Research Dive

Global Antiviral Therapy Market to Surpass USD 79.8 Million and Rise at a CAGR of 6.7% Owing to COVID-19 Chaos by 2026 – Exclusive Report [150 Pages] by Research Dive

New York, USA, Dec. 14, 2020 (GLOBE NEWSWIRE) -- According to a Research Dive published report, the global antiviral therapy market valued for $48.1 million in 2018 and is estimated to garner $79.8...